The prognosis and management of inactive HBV carriers

Federica Invernizzi, Mauro Viganò, Glenda Grossi, Pietro Lampertico

Research output: Contribution to journalArticlepeer-review


Patients with chronic hepatitis B virus (HBV) infection lacking the serum hepatitis B e antigen (HBeAg) and with antibodies against HBeAg (anti-HBe), are the prevalent subgroup of HBV carriers worldwide. The prognosis of these patients is different from inactive carriers (ICs), who are characterized by persistently normal serum alanine aminotransferase (ALT) and low (

Original languageEnglish
Pages (from-to)100-104
Number of pages5
JournalLiver International
Publication statusPublished - Jan 1 2016


  • Antiviral treatment
  • HCC
  • Hepatitis B virus
  • Inactive carriers
  • Natural history
  • Prophylaxis

ASJC Scopus subject areas

  • Hepatology


Dive into the research topics of 'The prognosis and management of inactive HBV carriers'. Together they form a unique fingerprint.

Cite this